Novo to Follow Lilly and Sell Obesity Shot Wegovy in Vials

Novo Nordisk A/S aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers it’s lost to rival Eli Lilly & Co.

Currently Novo sells the drug in plastic injector pens. Lilly launched vials nearly two years ago to offer a lower-priced version of its shot and alleviate shortages. It’s unclear what Novo will charge for vials, but the company already has been aggressively discounting its obesity drugs to compete.